Universal Diagnostics is a biotechnology firm that develops minimally invasive, blood-based solutions for the early detection of cancer.
Universal Diagnostics has raised $34.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.
Universal Diagnostics's investors include European Investment Bank, Quest Diagnostics, CDTI Innovación's INNVIERTE program, SETT, Adepa.
Universal Diagnostics is headquartered in Sevilla, Spain.
Universal Diagnostics is a biotechnology firm that develops minimally invasive, blood-based solutions for the early detection of cancer.
Universal Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Universal Diagnostics — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/universal-diagnostics. Accessed November 14, 2026.
VCBacked. (2026). Universal Diagnostics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/universal-diagnostics
{{cite web |title=Universal Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/universal-diagnostics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Universal Diagnostics? Request a listing update